have been used to analyze CF families from several countries and ethnic backgrounds. Markers surrounding the INTIL1 gene show strong associations, linkage disequilibrium, with the CF mutation (Beaudet et al. 1986; Estivill et al. 1989; Schmidtke et al. 1987) . Because the CF mutation is often on a haplotype that is infrequent in the general population these RFLPs are almost always informative in CF families. Relatively few RFLPs have been reported near D7S8, and this region shows only weak associations with CF (Estivill et al. 1989) .
Using chromsome jumping to isolate new sequences a large distance from D7S8, we recently reported the identification of several new RFLPs . Our initial data suggested that these new polymorphisms were in strong disequilibrium with D7S8. We now report data from several clinical centers on the usefulness of these probes to CF families.
Introduction
The discovery of linkage between markers on chromosome 7 and cystic fibrosis (CF) made possible carrier detection and prenatal diagnosis for families with a history of the disease (Dean et al. 1985 (Dean et al. , 1987 Farrall et al. 1986; Knowlton et al. 1985; Tsui et al. 1985; Wainwright et al. 1985; White et al. 1985 White et al. , 1986 Dean 1988) . The CF gene is flanked on one side by the MET and INT1L1 genes, and on the other by the D7S8 locus (Lathrop et al. 1988; Beaudet et al. 1986; Estivill et al. 1989) . Restriction fragment length polymorphisms (RFLPs) at these loci Offprint requests to: M. Dean
Materials and methods
DNA probes were labeled and used for Southern hybridization using standard techniques (Southern 1975; Feinberg and Vogelstein 1984) . Standardized linkage disequilibrium was calculated as described Hill and Robertson 1968) . Tests for homogeneity of linkage disequilibrium were performed as described (Laurie-Ahlberg and Weir 1979; Weir 1990) .
Results
Three previously reported RFLPs at the W32 (D7S424), and J29 (D7S426) locus were used by seven centers to type families requesting genetic diagnosis. W32 detects a Shown are the parents (half-filled) and CF child (filled) and the genotypes for several RFLPs. The mother is heterozygous for J29 EcoRV, whereas the father is homozygous. This allows the mother's CF and normal chromosomes to be followed SacI RFLP and is 60kb centromeric to D7S8; J29 detects EcoRV and PvuII polymorphisms and is 150kb telomeric to D7S8 . The majority of families were nuclear, comprising both parents and one affected child. In total 306 families were studied, although each marker was not typed in every individual.
The frequency of the RFLPs were not significantly different (at the 5% level) between the study groups (Table 1) . These new markers increased the heterozygosity of the D7S8 side of the gene from 50% to 58%, allowing a greater percentage of families to be informative. To examine the extent of linkage disequilibrium (A) between these markers and D7S8, haplotypes were generated. All marker-marker pairs showed strong association in all the populations studied, with standardized linkage disequilibrium values ranging from 0.62 to 1.0 (Table 2) . However, a statistically significant degree of heterogeneity over populations was found for marker pairs (data not shown). No correlation was found between the extent of disequilibrium and the distance between the probes. By analyzing haplotypes we found that only 11 of 16 possible haplotypes were present in 149 CF chromosomes, with two haplotypes (1-1-1-1, 2-2-2-2) comprising 83% of the sample. On normal chromosomes, 12 haplotypes were found out of 145 chromosomes, with the same two haplotypes accounting for 85% of the total. Thus there is a significant distortion in the distribution of haplotypes in this region.
Despite the modest increase in heterozygosity observed with these new probes, use has been made of the b Populations heterogeneous for linkage disequilibrium J29 EcoRV RFLP to achieve a fully informative diagnosis in one case. Here both parents and the affected child were heterozygous for several markers commonly used for prenatal diagnosis (Fig. 1) , thus marking it impossible to distinguish an affected from an unaffected fetus. The EcoRV RFLP was informative only in the mother, which allowed the maternal CF chromosome to be traced in the fetal DNA, and by combining this marker with the others, a prediction can be made from all possible genotypes. Low, but significant, values of linkage disequilibrium with CF have been reported for D7S8 (Estivill et al. 1989; Schmidtke et al. 1987) , and most of the centers in this study showed low A values for markers in this region and CF (Table 3) . Significant heterogeneity over populations was found for associations of CF with all markers except for the J29 PvuII RFLP. Two of the centers (BOS, ROT) show strikingly higher values than all the others. Both of these centers received patients from a dispersed area with no obvious concentration of any one geographical region. The BOS families were taken from all over North America, and the ROT sample includes families from several European countries (J.A. Amos, D.Halley, and B. Oostra, data not shown). Because all of the patients are Caucasians of European origin this discrepancy is hard to explain.
Due to the strong linkage disequilibrium exhibited between these new markers and D7S8, the RFLPs studied here will not be useful as primary markers for the analysis of CF families. These markers could certainly be used in the place of D7S8, and in the hands of some groups gave clearer results. However, as shown in Fig. 1 , these probes do provide additional information in certain cases. We estimate that 16% of individuals uniformative for D7S8 will be informative with one of these polymorphisms.
Discussion
Following the discovery of linkage between an RFLP marker and a disease gene, the next step is to identify markers flanking the gene, and further closely linked, highly polymorphic RFLPs. The rationale behind this strategy is to increase the applicability of genetic testing and pedigree analysis. With flanking markers, each 10 cM from the disease gene, a fully informative family can be diagnosed with an accuracy approaching 96%. Locus expansion, (isolating additional sequences flanking a marker using chromosome walking) usually results in the identification of additional polymorphisms, which increase the heterozygosity of the locus. For example, this strategy was used to increase the informativeness of markers linked to Huntington's chorea (Gilliam et al. 1987) . However, as reported here, large regions of DNA in linkage disequilibrium may frustrate such efforts. While the sequences surrounding D7S8 may not be typical of most loci, only a small portion of the human genome has been examined in this fashion, making it hard to predict the extent of disequilibrium in other regions. Rommens et al. (1989) have found a similar large stretch of DNA in disequilibrium between the INTIL1 gene and CF. Large regions of DNA in disequilibrium are more likely to occur for diseases like CF, which are restricted to specific racial groups, and have a low mutation rate. On the other hand, the presence of large regions in disequilibrium would aid the analysis of complex diseases that involve both genetic and environmental factors, and may require population genetics approaches.
The range of associations between D7S8 and CF in the different centers was surprising, given that almost all the families are Caucasian. This difference can be most likely explained by either the presence of actual differences in the populations or an artefact of the sample size. Since both the BOS and ROT populations are quite heterogeneous, the difference is most likely due to sample size. These two centers studied 42 and 35 families, respectively.
While this manuscript was in preparation the cloning of the CF gene, and the identification of a mutation present on 70% of CF chromosomes was described Riordan et al. 1989) . Presumably the remaining mutations will be identified, and the diagnosis of CF will involve the direct identification of mutations. In this case the markers described here will no longer be of use in prenatal diagnosis. However, the approaches and problems described will apply to the diagnosis of other genetic diseases as they progress from linkage to the identification of mutations.
